2010
DOI: 10.1507/endocrj.k09e-290
|View full text |Cite
|
Sign up to set email alerts
|

Glucocorticoid-induced gene tripartite motif-containing 63 (TRIM63) promotes differentiation of osteoblastic cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(11 citation statements)
references
References 25 publications
1
10
0
Order By: Relevance
“…The underlying mechanisms are unclear. Despite studies that show low‐dose GCs are positive regulators of bone formation in vitro or in vivo experiments [Kalak et al, ; Azuma et al, ]; they clearly inhibit bone formation in clinical therapy. Some researchers reported that GCs can induce adipogenic differentiation in bone marrow mesenchymal cells and can suppress their proliferation [Lin et al, ].…”
Section: Introductionmentioning
confidence: 99%
“…The underlying mechanisms are unclear. Despite studies that show low‐dose GCs are positive regulators of bone formation in vitro or in vivo experiments [Kalak et al, ; Azuma et al, ]; they clearly inhibit bone formation in clinical therapy. Some researchers reported that GCs can induce adipogenic differentiation in bone marrow mesenchymal cells and can suppress their proliferation [Lin et al, ].…”
Section: Introductionmentioning
confidence: 99%
“…TRIM63, also termed muscle-specific ring finger protein 1, has been reported as an E3 ubiquitin ligase expressed predominantly in muscular tissue. Azuma et al ( 35 ) proposed that the overexpression of TRIM63 increased the expression of an osteoblastic differentiation marker gene, alkaline phosphatase, resulting in reduced proliferation. In addition, TRIM63 was identified to be involved in the two major bone remodeling activities, osteoblastic bone formation and osteoclastic bone resorption ( 36 ).…”
Section: Discussionmentioning
confidence: 99%
“…The point mutants of HSP70 (K71S and V438F) and HSP90 (D88N) were created using PCR-based targeted mutagenesis and confirmed with DNA sequence analysis. The expression plasmids for HSP40 (HDJ1; [22]) and FLAG-TRIM63 [23] were provided by Drs. Ohtsuka (Gifu University) and Inoue (University of Tokyo), respectively.…”
Section: Methodsmentioning
confidence: 99%